amiodarone and pimobendan

amiodarone has been researched along with pimobendan in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL1
Lombardo, F; Obach, RS; Waters, NJ1
Abraham, M; Ambachew, B; Antonova-Koch, Y; Burrows, J; Calla, J; Campo, B; Chaumeau, V; Chen, K; Cheung, AL; Conway, AJ; Eribez, K; Fidock, DA; Gagaring, K; Gamo, FJ; Ibanez, M; Jado, JC; Kyle, DE; Lincoln, C; LlinĂ¡s, M; Lukens, AK; Luth, MR; Maher, SP; McNamara, CW; Meister, S; Nosten, F; Ottilie, S; Owen, E; Plouffe, D; Rouillier, M; Sakata-Kato, T; Serrano, FN; Siegel, D; Taggard, CM; Vanaerschot, M; Winzeler, EA; Wirth, DF; Zhong, Y; Zhou, Y1
Hagemeijer, F1
Kohno, M1

Reviews

1 review(s) available for amiodarone and pimobendan

ArticleYear
[Pharmacological treatment of heart failure].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 4

    Topics: Acute Disease; Adrenergic beta-Antagonists; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Infusions, Intravenous; Pyridazines; Tetrazoles; Valine; Valsartan; Vasodilator Agents

2003

Trials

1 trial(s) available for amiodarone and pimobendan

ArticleYear
Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: long-term effectiveness of add-on therapy with pimobendan.
    American heart journal, 1991, Volume: 122, Issue:2

    Topics: Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Digoxin; Diuretics; Female; Heart Failure; Humans; Male; Pyridazines; Survival Analysis; Vasodilator Agents

1991

Other Studies

3 other study(ies) available for amiodarone and pimobendan

ArticleYear
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
    Bioorganic & medicinal chemistry letters, 2005, Sep-15, Volume: 15, Issue:18

    Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride

2005
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.
    Science (New York, N.Y.), 2018, 12-07, Volume: 362, Issue:6419

    Topics: Antimalarials; Chemoprevention; Drug Discovery; Drug Evaluation, Preclinical; Humans; Malaria; Mitochondria; Plasmodium

2018